Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats

Psychopharmacology

Volumn 205, Issue 4, 2009, Pages 655-665

  Murray, Jennifer E ^a   Wells, Nicole R ^a   Lyford, George D ^a   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Appetitive conditioning; Associative learning; Cannabinoid receptor; Nicotinic acetylcholine; Occasion setting; Smoking cessation

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ENDOCANNABINOID; NICOTINE TARTRATE; RIMONABANT; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; EVOKED RESPONSE; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS GENERALIZATION; STIMULUS RESPONSE; TRAINING;

ANIMALS; CONDITIONING, CLASSICAL; CYCLOHEXANOLS; DISCRIMINATION LEARNING; DRUG INTERACTIONS; MALE; NICOTINE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

EID: 68149171936     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1572-x     Document Type: Article

References (52)

1. 1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders Behav Pharmacol 16 275 296
2. J Besheer MI Palmatier DM Metschke RA Bevins 2004 Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats Psychopharmacology (Berl.) 172 108 117
3. RA Bevins JJB Ayres 1991 Two issues in Pavlovian fear conditioning: selective fear of bright vs. dark, and CS determinants of CR form Behav Process 24 211 218
4. A Castañé E Valjent C Ledent M Parmentier R Maldonado O Valverde 2002 Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence Neuropharmacology 43 857 867
5. A Castañé F Berrendero R Maldonado 2005 The role of the cannabinoid system in nicotine addiction Pharmacol Biochem Behav 81 381 386
6. WT Chance D Murfin GM Krynock JA Rosencrans 1977 A description of the nicotine stimulus and tests of its generalization to amphetamine Psychopharmacology (Berl.) 55 19 26
7. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats Behav Pharmacol 13 451 463
8. C Cohen G Perrault G Griebel P Soubrie 2004 Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716) Neuropsychopharmacology 30 145 155
9. 9- tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice Prog Neuropsychopharmacol Biol Psychiatry 26 321 325
10. SN Davies RG Pertwee G Riedel 2002 Functions of cannabinoid receptors in the hippocampus Neuropharmacology 42 993 1007
11. TJ De Vries W De Vries MC Janssen AN Schoffelmeer 2005 Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A Behav Brain Res 161 164 168
12. J De Vry KR Jentzsch 2003 Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm Behav Pharmacol 14 471 476
13. BJ Farwell JJB Ayres 1979 Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking ("goal-tracking") in rats Learn Motiv 10 295 312
14. 1 receptors are involved in motivational effects of nicotine in rats Psychopharmacology (Berl.) 181 722 734
15. 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors Neurosci Lett 226 159 162
16. SD Glick S Milloy 1972 Increased and decreased eating following THC administration Psychon Sci 29 6
17. TV Jaeger RF Mucha 1990 A taste aversion model of drug discrimination learning: training drug and condition influence rate of learning, sensitivity and drug specificity Psychopharmacology 100 145 150
18. DJB Kim JD Brioni 1995 Modulation of the discriminative stimulus properties of (-)-nicotine by diazepam and ethanol Drug Dev Res 34 47 54
19. E Kodas C Cohen C Louis G Griebel 2007 Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling Psychopharmacology (Berl.) 194 161 171
20. L Lamota FJ Bermudez-Silva E-M Marco R Llorente A Gallego F Rodríguez de Fonseca M-P Viveros 2008 Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats Neuropharmacology 54 194 205
21. 1 antagonist, blocks nicotine-conditioned place preferences NeuroReport 15 2139 2143
22. AH Lichtman BR Martin 1996 Delta-9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism Psychopharmacology (Berl.) 126 125 131
23. AH Lichtman KR Dimen BR Martin 1995 Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats Psychopharmacology (Berl.) 119 282 290
24. PJ Little DR Compton MR Johnson LS Melvin BR Martin 1988 Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J Pharmacol Exp Ther 247 1046 1051
25. JHR Maes JMH Vossen 1997 Conditional control by midazolam and amphetamine in a rapid appetitive discrimination procedure Eur J Pharmacol 319 5 11
26. JHR Maes CM Van Rijn JMH Vossen 1996 Drug states as modulators of conditioned immobility in a latent discrimination procedure Eur J Pharmacol 309 131 140
27. F Mauler J Mittendorf E Horváth J De Vry 2002 Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy) phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties J Pharmacol Exp Ther 302 359 368
28. JE Murray RA Bevins 2007 Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus Eur J Pharmacol 561 91 104
29. JE Murray RA Bevins 2007 The conditional stimulus effects of nicotine vary as a function of training dose Behav Pharmacol 18 707 716
30. JE Murray C Li MI Palmatier RA Bevins 2007 The interoceptive Pavlovian stimulus effects of caffeine Pharmacol Biochem Behav 86 838 846
31. National Research Council (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research. National Academy Press, Washington, DC
32. MI Palmatier RA Bevins 2007 Facilitation by drug states does not depend on acquired excitatory strength Behav Brain Res 176 292 301
33. MI Palmatier RA Bevins 2008 Occasion setting by drug states: functional equivalence following similar training history Behav Brain Res 195 260 270
34. X Pan SR Ikeda DL Lewis 1998 SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity Mol Pharmacol 54 1064 1072
35. F Petitet B Jeantaud M Reibaud A Imperato MC Dubroeucq 1998 Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta-9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors Life Sci 63 PL1 PL6
36. CM Reichel RA Bevins 2008 Competition between the conditioned rewarding effects of cocaine and novelty Behav Neurosci 122 140 150
37. CM Reichel JD Linkugel RA Bevins 2007 Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications Exp Clin Psychopharmacol 15 501 509
38. CM Reichel JL Wilkinson RA Bevins 2007 Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task Behav Pharmacol 18 755 765
39. M Rinaldi-Carmona F Barth M Héaulme D Shire B Calandra C Congy S Martinez J Maruani G Néliat D Caput P Ferrara P Soubrié JC Brelière G Le Fur 1994 SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 240 244
40. M Rinaldi-Carmona F Barth C Cogny S Martinez D Oustric A Pério M Poncelet J Maruani M Arnone O Finance P Soubrié G Le Fur 2004 SR147778 [5-(4-Bromophenyl)-1-(2, 4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H- pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization J Pharmacol Exp Ther 310 905 914
41. M Ranganathan DC D'Souza 2006 The acute effects of cannabinoids on memory in humans: a review Psychopharmacology (Berl.) 188 425 444
42. L Robinson S [tmp] McKillop-Smith NL Ross RG Pertwee RE Hampson B Platt G Riedel 2008 Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats Psychopharmacology (Berl.) 198 551 563
43. Skinner DM, Goddard MJ, Holland PC (1998) What can nontraditional features tell us about conditioning and occasion setting? In: Schmajuk NA, Holland PC (eds) Occasion setting: Associative learning and cognition in animals. American Psychological Association, Washington, DC, pp 113-144
44. AJ Tallett JE Blundell RJ Rodgers 2007 Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats Psychopharmacology (Berl.) 195 27 39
45. BF Thomas AF Gilliam DF Burch MJ Roche HH Seltzman 1998 Comparative receptor binding analyses of cannabinoid agonists and antagonists J Pharmacol Exp Ther 285 285 292
46. JR Troisi C Akins 2004 The discriminative stimulus effects of cocaine in a Pavlovian sexual approach paradigm in male Japanese quail Exp Clin Psychopharmacol 12 237 242 (Pubitemid 39507746)
47. JL Wiley RL Barrett J Lowe RL Balster BR Martin 1995 Discriminative stimulus effects of CP 55, 940 and structurally dissimilar cannabinoids in rats Neuropharmacology 34 669 676
48. J Wiley R Balster B Martin 1995 Discriminative stimulus effects of anandamide in rats Eur J Pharmacol 276 49 54
49. JL Wilkinson C Li RA Bevins 2008 Pavlovian drug discrimination with bupropion as a feature positive occasion setter: Substitution by methamphetamine and nicotine, but not cocaine Addict Biol 14 165 173
50. S Xie MA Furjanic JJ Ferrara NR [tmp] McAndrew EL Ardino A Ngondara Y Bernstein KJ Thomas E Kim JM Walker S Nagar SJ Ward RB Raffa 2007 The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism-or inverse agonism-as potential obesity treatment and other therapeutic use J Clin Pharm Ther 32 209 231
51. ES Zakharova W Danysz AY Bespalov 2005 Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats Psychopharmacology (Berl.) 179 128 135
52. M Zaniewska AC [tmp] McCreary E Przegaliński M Filip 2006 Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats Eur J Pharmacol 540 96 106